clinicaltrialsarena2h
BMS’ Phase II trial of CAR T cell therapy meets primary endpoint
BMS has reported that the Phase II TRANSCEND FL trial assessing Breyanzi, met its primary endpoint in the marginal zone ...
clinicaltrialsarena14h
Boehringer seeks approval of lung disease drug after second Phase III success
Nerandomilast is posed to be Boehringer Ingelheim’s successor to its blockbuster Ofev (nintedanib)in IPF and PPF.
clinicaltrialsarena19h
Radiopharm’s imaging molecule hits mark in observational trial
Radiopharm Theranostics’ RAD 101 imaging molecule identified brain tumours in all 12 treatment-naïve patients in a ...
clinicaltrialsarena20h
Regeneron’s macular oedema therapy shows promise in Phase III trial
Regeneron has reported positive outcomes from the Phase III trial of Eylea HD in treating individuals with macular oedema ...
clinicaltrialsarena23h
Cyclo Therapeutics logs efficacy win in pivotal Niemann-Pick disease trial
Cyclo Therapeutics’ Trappsol Cyclo was able to induce clinical improvement in seven out of eight children with Neimann-Pick ...